Project Grant R25CA291597
Award Date 9/23/25
Completion Date 8/31/30
Dollars Obligated $299K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This $132,270 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports the development and application of whole-body patient-specific computational mesh phantoms. The goal is to use these phantoms in Monte Carlo radiation transport simulations to accurately compute radiation doses to organs distal to the treatment field, enabling better assessment of second primary cancer risks following external beam radiotherapy treatment. The award...
- This Project Grant award of $123,135 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) aims to develop physics-informed machine learning techniques for quantitative magnetic resonance imaging (MRI) to evaluate focused ultrasound breast cancer treatments. The primary awardee, the University of Utah, will investigate integrating physics knowledge into deep learning models to enable reliable and clinically deployable quantitative MRI methods. The project focuses on...
- This Project Grant award from the National Cancer Institute's (CFDA 93.394 - Cancer Detection and Diagnosis Research) will fund a research project titled "Innovative Scan Protocols with Combined Long Axial FOV PET and Spectral CT for Improved Quantification in Oncology". The $666,670 award, effective January 15, 2025, aims to develop advanced imaging protocols and processing techniques that utilize both positron emission tomography (PET) and spectral computed tomography (CT) to enhance...
- The National Cancer Institute awarded a $307,680 Project Grant to the University of Wisconsin-Madison (UW) under the Cancer Research Manpower (CFDA 93.398) program. The grant, titled "ASSURE ADVANCED RADIOLOGICAL SCIENCES PROGRAM," aims to establish an immersive summer research experience in radiological sciences for 17 undergraduate students. The program will provide cancer-focused scientific training, including didactic lectures, mentored research experiences, and interactive...
- This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding to The Trustees of the University of Pennsylvania to support the development and implementation of NCI-sponsored clinical trials for rare cancers. The $122,610 award, which began in August 2025, aims to: Assist junior and mid-career oncology faculty in developing investigator-initiated studies, and Develop a program within the National Clinical Trials Network (NCTN) to design...
- The University of Pennsylvania received a $597,766 Project Grant from the National Cancer Institute (CFDA Program 93.394 - Cancer Detection and Diagnosis Research) to develop methods for dual-tracer multiparametric imaging with a long-axial field-of-view PET scanner. The project aims to enable the simultaneous imaging of two different PET radiotracers in a single session, which would improve the characterization of cancer and transform precision medicine guided by molecular imaging. The 5-year...
- This $149,394 Project Grant was awarded on August 1, 2025 by the National Cancer Institute (NCI), part of the Department of Health and Human Services, under the federal Cancer Detection and Diagnosis Research program (CFDA 93.394). The grant supports research led by the University of California, Davis to advance the development of targeted radiopharmaceuticals for cancer diagnosis and therapy. Specifically, the research focuses on designing, synthesizing, and optimizing novel molecular imaging...
- This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research by the University of Texas MD Anderson Cancer Center to develop a Globally Accessible and Pragmatic Predictive Signature (GAPPS) for risk stratification of patients with locally advanced cervical cancer. The $498,565 award is intended to address the need for evidence-based, globally applicable early-treatment biomarkers to optimize radiation...
- This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides funding of $513,542.00 to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, to conduct research on the role of p53 in regulating chaperone-mediated autophagy and its impact on tumorigenesis. The research aims to define the mechanisms by which p53, a frequently mutated gene in human cancers, suppresses tumor...
- This federal Project Grant award of $545,078, funded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research), is supporting research at The Johns Hopkins University to investigate the use of radiopharmaceutical therapy in combination with inhibition of glutamine metabolism as a novel therapeutic strategy for prostate cancer and renal cell carcinoma. The project aims to systematically evaluate the effect of prostate-specific membrane antigen (PSMA)-based radiopharmaceutical...